Abbott price target raised to $133 from $131 at Wells Fargo

Wells Fargo raised the firm’s price target on Abbott to $133 from $131 and keeps an Overweight rating on the shares. The firm notes Abbott reported a Q4 sales beat, while EPS was in line. Its 2024 base business guidance of 8%-10% is above Wells’ expectations, with EPS guide bracketing Street, though Abbott noted there is potential for EPS to come in at the upper end of the range.